Loading chart…
PRE-MARKET
Procter & Gamble Health Limited manufactures and markets pharmaceutical and chemical products in India and internationally. It offers over-the-counter products, vitamins, minerals, and supplements under the Betamil, Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen brand names. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019.
Procter & Gamble Health Limited (PGHL) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The PGHL share price is ₹5,556.00 (-0.87% today), with a market capitalisation of ₹92B and a price-to-earnings (P/E) ratio of 26.5. MarketRipple tracks the PGHL investment thesis, the ripple-chain impact of market events on Procter & Gamble Health Limited, and the Healthcare sector outlook.
Open
₹5,600.00
High
₹5,600.00
Low
₹5,485.00
Prev. Close
₹5,605.00
52W High
₹6,975.00
52W Low
₹4,707.00
Day range
₹5,485.00–₹5,600.00
52-week range
₹4,707.00–₹6,975.00
Volume
6K
P/E
26.5
ROE
62.3%
D/E
0.02
Margin
24.9%
Procter & Gamble Health Limited (NSE: PGHL) is currently trading at ₹5,556.00 (-0.87%).
Procter & Gamble Health Limited's market capitalization is ₹92B.
Procter & Gamble Health Limited's price-to-earnings (P/E) ratio is 26.5.
Procter & Gamble Health Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Procter & Gamble Health Limited currently reads neutral, based on 1 analyst covering the stock. This is third-party analyst data, not a MarketRipple recommendation.